|Year : 1998 | Volume
| Issue : 2 | Page : 105--108
Efficacy and tolerability of oral sumatriptan in Indian patients with acute migraine : a multicentre study.
MV Padma, S Jain, MC Maheshwari, S Misra, B Karak, AK Singh, AK Meena, CK Katiyar, P Tiwari
Department of Neurology, All Institute of Medical Sciences, New Delhi - 110 029, India
This multicentre, randomized, double-blind, cross over, placebo controlled study evaluated the efficacy and tolerability of oral Sumatriptan (100 mg) in 100 migraineurs. 59 patients completed the study. The results indicate that by 4 hours post-dose62 of patients treated with Sumatriptan achieved relief of headache, compared with 10 of patients treated with placebo. The results show that oral Sumatriptan is an effective drug for treatment of acute migraine in Indian patients, though smaller dosage may be more beneficial.
Department of Neurology, All Institute of Medical Sciences, New Delhi - 110 029
Source of Support: None, Conflict of Interest: None
[PDF Not available]*